These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 4084664)
1. Isomers of broparoestrol and antiestrogen action: comparison with tamoxifen. Edery M; Barnova A; Drosdowsky M; Guggiari M; Vives C; Rudali G Biomed Pharmacother; 1985; 39(6):326-30. PubMed ID: 4084664 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen. O'Brian CA; Ioannides CG; Ward NE; Liskamp RM Biopolymers; 1990 Jan; 29(1):97-104. PubMed ID: 2158363 [TBL] [Abstract][Full Text] [Related]
3. [Action of an antiestrogen agent, tamoxifen on the uterus and vagina of the ovariectomized rat]. Marois M; Marois G C R Seances Soc Biol Fil; 1977; 171(2):280-6. PubMed ID: 142543 [TBL] [Abstract][Full Text] [Related]
4. Effects of daily anti-estrogen treatment on uterine growth and progesterone receptor concentrations in adult rat uterus. Janssens JP; Billiet G; Bonte J; De Loecker W Anticancer Res; 1984; 4(3):157-62. PubMed ID: 6465854 [TBL] [Abstract][Full Text] [Related]
5. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [TBL] [Abstract][Full Text] [Related]
6. Geometric isomers of substituted triphenylethylenes and antiestrogen action. Jordan VC; Haldemann B; Allen KE Endocrinology; 1981 Apr; 108(4):1353-61. PubMed ID: 6781873 [TBL] [Abstract][Full Text] [Related]
7. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. O'Connor JC; Cook JC; Craven SC; Van Pelt CS; Obourn JD Fundam Appl Toxicol; 1996 Oct; 33(2):182-95. PubMed ID: 8921337 [TBL] [Abstract][Full Text] [Related]
8. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats. Janssens JP; Billiet G; Bonte J; De Loecker W Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984 [TBL] [Abstract][Full Text] [Related]
9. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure. Jordan VC; Lieberman ME Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293 [TBL] [Abstract][Full Text] [Related]
10. Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat. Fitts JM; Klein RM; Powers CA J Pharmacol Exp Ther; 1998 Jul; 286(1):392-402. PubMed ID: 9655884 [TBL] [Abstract][Full Text] [Related]
11. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression. Huynh H; Pollak M Cancer Res; 1994 Jun; 54(12):3115-9. PubMed ID: 7515764 [TBL] [Abstract][Full Text] [Related]
12. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen. Bhattacharyya N; Ramsammy R; Eatman E; Hollis VW; Anderson WA J Submicrosc Cytol Pathol; 1994 Apr; 26(2):147-62. PubMed ID: 8019941 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol. Sato T; Ohta Y; Okamura H; Hayashi S; Iguchi T Anat Rec; 1996 Mar; 244(3):374-85. PubMed ID: 8742702 [TBL] [Abstract][Full Text] [Related]
14. Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse. Carthew P; Edwards RE; Nolan BM Toxicol Appl Pharmacol; 1999 Jul; 158(1):24-32. PubMed ID: 10387929 [TBL] [Abstract][Full Text] [Related]
15. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model. Yue W; Wang J; Savinov A; Brodie A Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729 [TBL] [Abstract][Full Text] [Related]
16. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma]. Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321 [TBL] [Abstract][Full Text] [Related]
17. Ligand interaction at the estrogen receptor to program antiestrogen action: a study with nonsteroidal compounds in vitro. Jordan VC; Koch R; Langan S; McCague R Endocrinology; 1988 Apr; 122(4):1449-54. PubMed ID: 3345720 [TBL] [Abstract][Full Text] [Related]
18. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related]
19. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues. Brown K; Brown JE; Martin EA; Smith LL; White IN Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484 [TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay. Tong S; Chen Q; Shan SQ; Dewhirst MW; Yuan F Angiogenesis; 2006; 9(2):53-8. PubMed ID: 16622786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]